Trials / Completed
CompletedNCT01574430
Study of Photodynamic Therapy (PDT) in Patients With Central Serous Chorioretinopathy (CSC)
A Randomized, Double-masked, Multicenter, Controlled Study of Photodynamic Therapy in Patients With Central Serous Chorioretinopathy
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 131 (estimated)
- Sponsor
- Peking University People's Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the safety and efficacy of PDT at 30% verteporfin dose in the treatment of CSC.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | PDT | 30% or 50% verteporfin dose PDT was given to patients with CSC |
Timeline
- Start date
- 2010-12-01
- Primary completion
- 2012-12-01
- Completion
- 2014-12-01
- First posted
- 2012-04-10
- Last updated
- 2016-08-16
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01574430. Inclusion in this directory is not an endorsement.